Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma (original) (raw)

• Biankin, A.V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399–405 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801–1806 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495–501 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Collisson, E.A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500–503 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Crnogorac-Jurcevic, T. et al. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 21, 4587–4594 (2002).
  Article CAS PubMed Google Scholar
• Witkiewicz, A.K. et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat. Commun. 6, 6744 (2015).
  Article CAS PubMed Google Scholar
• Iacobuzio-Donahue, C.A. et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol. 162, 1151–1162 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Logsdon, C.D. et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 63, 2649–2657 (2003).
  CAS PubMed Google Scholar
• Stuart, R.O. et al. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc. Natl. Acad. Sci. USA 101, 615–620 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y. et al. In silico estimates of tissue components in surgical samples based on expression profiling data. Cancer Res. 70, 6448–6455 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).
  Article CAS PubMed Google Scholar
• Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Campbell, P.J. & Stratton, M.R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246–259 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Alexandrov, L.B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Biton, A. et al. Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes. Cell Rep. 9, 1235–1245 (2014).
  Article CAS PubMed Google Scholar
• Stratford, J.K. et al. A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. PLoS Med. 7, e1000307 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Whitfield, M.L. et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 13, 1977–2000 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Froeling, F.E. et al. Retinoic acid—induced pancreatic stellate cell quiescence reduces paracrine Wnt–β-catenin signaling to slow tumor progression. Gastroenterology 141, 1486–1497 (2011).
  Article CAS PubMed Google Scholar
• Özdemir, B.C. et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25, 719–734 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Rhim, A.D. et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25, 735–747 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, J.J. et al. Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc. Natl. Acad. Sci. USA 111, E3091–E3100 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Olive, K.P. et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457–1461 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Erkan, M. et al. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin. Gastroenterol. Hepatol. 6, 1155–1161 (2008).
  Article PubMed Google Scholar
• Cohen, S.J. et al. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas 37, 154–158 (2008).
  Article CAS PubMed Google Scholar
• Hwang, R.F. et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 68, 918–926 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Vonlaufen, A. et al. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 68, 2085–2093 (2008).
  Article CAS PubMed Google Scholar
• Herrera, M. et al. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature. Clin. Cancer Res. 19, 5914–5926 (2013).
  Article CAS PubMed Google Scholar
• Nones, K. et al. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int. J. Cancer 135, 1110–1118 (2014).
  Article CAS PubMed Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315–322 (2014).
• Damrauer, J.S. et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc. Natl. Acad. Sci. USA 111, 3110–3115 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• McConkey, D.J., Choi, W. & Dinney, C.P. New insights into subtypes of invasive bladder cancer: considerations of the clinician. Eur. Urol. 67, e76–e78 (2015).
  Article PubMed Google Scholar
• Parker, J.S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160–1167 (2009).
  Article PubMed PubMed Central Google Scholar
• Prat, A. et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 12, R68 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Tibshirani, R., Hastie, T., Narasimhan, B. & Chu, G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. USA 99, 6567–6572 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Isella, C. et al. Stromal contribution to the colorectal cancer transcriptome. Nat. Genet. 47, 312–319 (2015).
  Article CAS PubMed Google Scholar
• Rubio-Viqueira, B. et al. An in vivo platform for translational drug development in pancreatic cancer. Clin. Cancer Res. 12, 4652–4661 (2006).
  Article CAS PubMed Google Scholar
• Stolze, B., Reinhart, S., Bulllinger, L., Fröhling, S. & Scholl, C. Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines. Sci. Rep. 5, 8535 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Ihle, N.T. et al. Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J. Natl. Cancer Inst. 104, 228–239 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Carey, L., Winer, E., Viale, G., Cameron, D. & Gianni, L. Triple-negative breast cancer: disease entity or title of convenience? Nat. Rev. Clin. Oncol. 7, 683–692 (2010).
  Article PubMed Google Scholar
• Bardeesy, N. et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 20, 3130–3146 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Haeger, S.M. et al. Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors. Oncogene 10.1038/onc.2015.112 (20 April 2015).
• Garrido-Laguna, I. et al. Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer. Clin. Cancer Res. 17, 5793–5800 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Dal Molin, M. et al. Very long-term survival following resection for pancreatic cancer is not explained by commonly mutated genes: results of whole-exome sequencing analysis. Clin. Cancer Res. 21, 1944–1950 (2015).
  Article CAS PubMed Google Scholar
• Zhang, Y. et al. A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat. Genet. 40, 862–870 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Zhong, Y. et al. GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1. PLoS ONE 6, e22129 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wamunyokoli, F.W. et al. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clin. Cancer Res. 12, 690–700 (2006).
  Article CAS PubMed Google Scholar
• Ji, H. et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 448, 807–810 (2007).
  Article CAS PubMed Google Scholar
• Croft, D. et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 42, D472–D477 (2014).
  Article CAS PubMed Google Scholar
• Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25–29 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Bild, A.H. et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439, 353–357 (2006).
  Article CAS PubMed Google Scholar
• Nishimura, D. BioCarta. Biotech. Software Internet Rep. 2, 117–120 (2001).
  Article Google Scholar
• Shi, L. et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat. Biotechnol. 28, 827–838 (2010).
  Article CAS PubMed Google Scholar
• Hoadley, K.A. et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158, 929–944 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Iacobuzio-Donahue, C.A. et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J. Clin. Oncol. 27, 1806–1813 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550 (2005).
  CAS PubMed PubMed Central Google Scholar
• Neel, N.F. et al. Response to MLN8237 in pancreatic cancer is not dependent on RalA phosphorylation. Mol. Cancer Ther. 13, 122–133 (2014).
  Article CAS PubMed Google Scholar
• Bachem, M.G. et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128, 907–921 (2005).
  Article CAS PubMed Google Scholar
• Conway, T. et al. Xenome—a tool for classifying reads from xenograft samples. Bioinformatics 28, i172–i178 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562–578 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012).